文献速递产科母胎医学

普遍宫颈长度筛查与产前糖皮质激素给药时机

Universal Cervical Length Screening and Antenatal Corticosteroid Timing.
PubMed 文献 · Obstet Gynecol · 2017-01-01

本研究为回顾性队列研究,纳入2012年10月至2015年8月启动普遍经阴道宫颈长度筛查项目后、孕24至34周自发早产的单胎非畸形妊娠患者266例,其中宫颈短69例、宫颈不短197例。宫颈短组分娩前接受至少一次糖皮质激素比例为92.8%(64/69),宫颈不短组为89.3%(176/197),两组差异无统计学意义(P=.411)。宫颈短组给药至分娩间隔不足7天者占47.8%(33/69),低于宫颈不短组的64%(126/197),差异有统计学意义(P=.015;调整比值比0.51,95%置信区间0.29-0.9)。宫颈短组给药至分娩中位间隔为8天,宫颈不短组为3天(P<.001)。

要点

  • 宫颈短组给药至分娩间隔不足7天者占47.8%(33/69),低于宫颈不短组的64%(126/197),P=.015。
  • 宫颈短组给药至分娩中位间隔为8天,宫颈不短组为3天,P<.001。
  • 宫颈短组分娩前接受至少一次糖皮质激素比例为92.8%(64/69),宫颈不短组为89.3%(176/197),P=.411。

核心结论

  • 经普遍经阴道超声筛查发现宫颈短的患者,与宫颈不短者相比,在启动糖皮质激素促胎肺成熟后超过7天分娩的风险更高。

研究设计与样本

  • 回顾性队列研究,纳入2012年10月至2015年8月启动普遍经阴道宫颈长度筛查项目后、孕24至34周自发早产的单胎非畸形妊娠患者266例,其中宫颈短69例、宫颈不短197例。

主要发现

  • 宫颈短组分娩前接受至少一次糖皮质激素比例为92.8%(64/69),宫颈不短组为89.3%(176/197),P=.411。
  • 宫颈短组给药至分娩间隔不足7天者占47.8%(33/69),宫颈不短组为64%(126/197),P=.015;调整比值比0.51,95%置信区间0.29-0.9。
  • 宫颈短组给药至分娩中位间隔为8天,宫颈不短组为3天,P<.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relationship between universal transvaginal screening for short cervical length in the second trimester and the timing of antenatal corticosteroids. METHODS: We performed a retrospective cohort study of patients with nonanomalous singleton gestations and spontaneous preterm birth between 24 and 34 weeks of gestation after the initiation of a universal transvaginal cervical length screening program between October 2012 and August 2015. Our primary outcome was antenatal corticosteroid administration to a delivery interval of fewer than 7 days. Secondary outcomes were delivery 24 hours to 7 days after the initial steroid injection, steroid administration to delivery interval, neonatal survival, neonatal intensive care unit length of stay, and respiratory distress syndrome. Multivariable logistic regression was used to estimate the association between antenatal corticosteroid timing and the diagnosis of a short cervix adjusted for potential confounders. RESULTS: Among 266 eligible patients, 69 with a short cervical length and 197 without a short cervical length were identified. There were no statistically significant differences in baseline characteristics between the groups. During the study period, 64 of 69 (92.8%) of patients with a short cervix and 176 of 197 (89.3%) without a short cervix received at least one steroid injection before delivery (P=.411). Steroids were given within 7 days of delivery in 33 of 69 (47.8) patients with a short cervix compared with 126 of 197 (64%) patients in the no short cervix group (P=.015; adjusted odds ratio 0.51, 95% confidence interval 0.29-0.9). Median interval between steroid administration and delivery was 8 days in patients diagnosed with a short cervix compared with 3 days for those without a short cervical length (P<.001). CONCLUSION: Patients identified as having a short cervical length by universal transvaginal ultrasound screening were at greater risk of delivering more than 7 days after the initiation of corticosteroids for fetal lung maturation compared with women without a short cervical length.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sahasrabudhe N, Igel C, Echevarria GC, et al. Universal Cervical Length Screening and Antenatal Corticosteroid Timing. Obstet Gynecol. 2017. PMID: 28486361. doi:10.1097/AOG.0000000000002029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。